Cravath represented Viatris in the transaction, while White & Case advised Famy Life Sciences. Famy Life Sciences, a market-leading drug development platform, announced its entry into...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here